Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs

被引:33
|
作者
Choi, Kyeong-Ok [1 ]
Choe, Jaehyeog [1 ]
Suh, Seokjin [1 ]
Ko, Sanghoon [1 ]
机构
[1] Sejong Univ, Dept Food Sci & Technol, 261 Neungdong Ro, Seoul 143747, South Korea
来源
MOLECULES | 2016年 / 21卷 / 05期
基金
新加坡国家研究基金会;
关键词
poorly water soluble drug; indomethacin; nanostructured lipid nanocarrier; N-(2-hydroxy)propyl-3-trimethyl ammonium chitosan chloride; in vitro release; CHITOSAN; NANOPARTICLES; SURFACE; FORMULATION; PH;
D O I
10.3390/molecules21050672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study is to develop suitable formulations to improve the dissolution rate of poorly water soluble drugs. We selected lipid-based formulation as a drug carrier and modified the surface using positively charged chitosan derivative (HTCC) to increase its water solubility and bioavailability. Chitosan and HTCC-coated lipid particles had higher zeta-potential values than uncoated one over the whole pH ranges and improved encapsulation efficiency. In vitro drug release showed that all NLC formulations showed higher in vitro release efficiency than drug particle at pH 7.4. Furthermore, NLC formulation prepared with chitosan or HTCC represented good sustained release property. The results indicate that chitosan and HTCC can be excellent formulating excipients of lipid-based delivery carrier for improving poorly water soluble drug delivery.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] ENHANCEMENT OF THE DISSOLUTION RATES OF POORLY WATER-SOLUBLE DRUGS BY WATER-SOLUBLE GELATIN
    IMAI, T
    NISHIYAMA, T
    UENO, M
    OTAGIRI, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1989, 37 (08) : 2251 - 2252
  • [42] Modifying the Diffusion Layer of Soluble Salts of Poorly Soluble Basic Drugs To Improve Dissolution Performance
    Hawley, Michael
    Morozowich, Walter
    MOLECULAR PHARMACEUTICS, 2010, 7 (05) : 1441 - 1449
  • [43] Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers
    Friedrich, H
    Fussnegger, B
    Kolter, K
    Bodmeier, R
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 62 (02) : 171 - 177
  • [44] Improvement of dissolution of poorly soluble glimepiride by loading on two types of mesoporous silica carriers
    Tzankov, Borislav
    Voycheva, Christina
    Aluani, Denitsa
    Yordanov, Yordan
    Avramova, Kati
    Tzankova, Virginia
    Spassova, Ivanka
    Kovacheva, Daniela
    Yoncheva, Krassimira
    JOURNAL OF SOLID STATE CHEMISTRY, 2019, 271 : 253 - 259
  • [45] Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs
    Rasenack, N
    Müller, BW
    PHARMACEUTICAL RESEARCH, 2002, 19 (12) : 1894 - 1900
  • [46] Dissolution rate enhancement by adsorption of poorly soluble drugs on hydrophilic silica aerogels
    Smirnova, I
    Suttiruengwong, S
    Seiler, M
    Arlt, W
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2004, 9 (04) : 443 - 452
  • [47] Mesoporous silica nanoparticles facilitating the dissolution of poorly soluble drugs in orodispersible films
    Sen Karaman, Didem
    Patrignani, Giorgia
    Rosqvist, Emil
    Smatt, Jan-Henrik
    Orlowska, Aleksandra
    Mustafa, Rawand
    Preis, Maren
    Rosenholm, Jessica M.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 122 : 152 - 159
  • [48] The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs
    Park, Sung-Hyun
    Choi, Hoo-Kyun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 321 (1-2) : 35 - 41
  • [49] Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs
    Norbert Rasenack
    Bernd W. Müller
    Pharmaceutical Research, 2002, 19 : 1894 - 1900
  • [50] Evaluation of β-glucan particles as dual-function carriers for poorly soluble drugs
    Salamunova, Petra
    Salon, Ivan
    Ruphuy, Gabriela
    Kroupova, Jirina
    Balouch, Martin
    Hanus, Jaroslav
    Stepanek, Frantisek
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2021, 168 : 15 - 25